Found: 136
Select item for more details and to access through your institution.
Comparison of pegfilgrastim on day 2 vs. day 4 as primary prophylaxis of intense dose-dense chemotherapy in patients with node-positive primary breast cancer within the prospective, multi-center GAIN study: (GBG 33).
- Published in:
- 2011
- By:
- Publication type:
- journal article
Breakthroughs in research and treatment of early breast cancer: an overview of the last three decades.
- Published in:
- Archives of Gynecology & Obstetrics, 2013, v. 288, n. 6, p. 1203, doi. 10.1007/s00404-013-3069-4
- By:
- Publication type:
- Article
Predictive Factors for Response to Neoadjuvant Therapy in Breast Cancer.
- Published in:
- Oncology Research & Treatment, 2014, v. 37, n. 10, p. 563, doi. 10.1159/000367643
- By:
- Publication type:
- Article
Downregulation of human polo-like kinase activity by antisense oligonucleotides induces growth inhibition in cancer cells.
- Published in:
- Oncogene, 2002, v. 21, n. 20, p. 3162
- By:
- Publication type:
- Article
PIK3CA H1047R Mutation Associated with a Lower Pathological Complete Response Rate in Triple-Negative Breast Cancer Patients Treated with Anthracycline-Taxane-Based Neoadjuvant Chemotherapy.
- Published in:
- Cancer Research & Treatment, 2020, v. 52, n. 3, p. 689, doi. 10.4143/crt.2019.497
- By:
- Publication type:
- Article
Cost-Effectiveness Analysis of Prognostic Gene Expression Signature-Based Stratification of Early Breast Cancer Patients.
- Published in:
- PharmacoEconomics, 2015, v. 33, n. 2, p. 179, doi. 10.1007/s40273-014-0227-x
- By:
- Publication type:
- Article
Anti-epidermal growth factor receptor-antibody therapy for treatment of breast cancer.
- Published in:
- International Journal of Cancer, 2002, v. 101, n. 4, p. 390, doi. 10.1002/ijc.10615
- By:
- Publication type:
- Article
Gonadotropin-Releasing Hormone Analogue for Premenopausal Women With Breast Cancer.
- Published in:
- 2011
- By:
- Publication type:
- Letter
Characterization of Hormone Receptor and HER2 Status in Breast Cancer Using Mass Spectrometry Imaging.
- Published in:
- International Journal of Molecular Sciences, 2023, v. 24, n. 3, p. 2860, doi. 10.3390/ijms24032860
- By:
- Publication type:
- Article
Radiological Patterns of Brain Metastases in Breast Cancer Patients: A Subproject of the German Brain Metastases in Breast Cancer (BMBC) Registry.
- Published in:
- International Journal of Molecular Sciences, 2016, v. 17, n. 10, p. 1615, doi. 10.3390/ijms17101615
- By:
- Publication type:
- Article
EVI1 expression in early-stage breast cancer patients treated with neoadjuvant chemotherapy.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Intensified Neoadjuvant Chemotherapy in Early-Responding Breast Cancer: Phase Ill Randomized GeparTrio Study.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2008, v. 100, n. 8, p. 552, doi. 10.1093/jnci/djn089
- By:
- Publication type:
- Article
Effect of Tailored Dose-Dense Chemotherapy vs Standard 3-Weekly Adjuvant Chemotherapy on Recurrence-Free Survival Among Women With High-Risk Early Breast Cancer: A Randomized Clinical Trial.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Repurposing anticancer drugs for COVID-19-induced inflammation, immune dysfunction, and coagulopathy.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Prevalence of pathogenic BRCA1/2 germline mutations among 802 women with unilateral triple-negative breast cancer without family cancer history.
- Published in:
- 2018
- By:
- Publication type:
- journal article
A clinical calculator to predict disease outcomes in women with hormone receptor-positive advanced breast cancer treated with first-line endocrine therapy.
- Published in:
- Breast Cancer Research & Treatment, 2021, v. 189, n. 1, p. 15, doi. 10.1007/s10549-021-06319-z
- By:
- Publication type:
- Article
Clinical and analytical validation of Ki-67 in 9069 patients from IBCSG VIII + IX, BIG1-98 and GeparTrio trial: systematic modulation of interobserver variance in a comprehensive in silico ring trial.
- Published in:
- Breast Cancer Research & Treatment, 2019, v. 176, n. 3, p. 557, doi. 10.1007/s10549-018-05112-9
- By:
- Publication type:
- Article
Outcome after neoadjuvant chemotherapy in estrogen receptor-positive and progesterone receptor-negative breast cancer patients: a pooled analysis of individual patient data from ten prospectively randomized controlled neoadjuvant trials.
- Published in:
- Breast Cancer Research & Treatment, 2018, v. 167, n. 1, p. 59, doi. 10.1007/s10549-017-4480-5
- By:
- Publication type:
- Article
Efficacy and safety of nab-paclitaxel 125 mg/m and nab-paclitaxel 150 mg/m compared to paclitaxel in early high-risk breast cancer. Results from the neoadjuvant randomized GeparSepto study (GBG 69).
- Published in:
- Breast Cancer Research & Treatment, 2017, v. 163, n. 3, p. 495, doi. 10.1007/s10549-017-4200-1
- By:
- Publication type:
- Article
Outcome after neoadjuvant chemotherapy in young breast cancer patients: a pooled analysis of individual patient data from eight prospectively randomized controlled trials.
- Published in:
- Breast Cancer Research & Treatment, 2015, v. 152, n. 2, p. 377, doi. 10.1007/s10549-015-3479-z
- By:
- Publication type:
- Article
Phase III study on efficacy of taxanes plus bevacizumab with or without capecitabine as first-line chemotherapy in metastatic breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2015, v. 149, n. 1, p. 141, doi. 10.1007/s10549-014-3217-y
- By:
- Publication type:
- Article
Changes in serum levels of miR-21, miR-210, and miR-373 in HER2-positive breast cancer patients undergoing neoadjuvant therapy: a translational research project within the Geparquinto trial.
- Published in:
- Breast Cancer Research & Treatment, 2014, v. 147, n. 1, p. 61, doi. 10.1007/s10549-014-3079-3
- By:
- Publication type:
- Article
RANK expression as a prognostic and predictive marker in breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2014, v. 145, n. 2, p. 307, doi. 10.1007/s10549-014-2955-1
- By:
- Publication type:
- Article
Response and prognosis after neoadjuvant chemotherapy in 1,051 patients with infiltrating lobular breast carcinoma.
- Published in:
- Breast Cancer Research & Treatment, 2014, v. 144, n. 1, p. 153, doi. 10.1007/s10549-014-2861-6
- By:
- Publication type:
- Article
Prognostic impact of HER3 based on protein and mRNA expression in high-grade serous ovarian carcinoma.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Comparative biomarker analysis of PALOMA-2/3 trials for palbociclib.
- Published in:
- NPJ Precision Oncology, 2022, v. 6, n. 1, p. 1, doi. 10.1038/s41698-022-00297-1
- By:
- Publication type:
- Article
Impact of Age on Clinical Outcomes and Efficacy of Adjuvant Dual Anti-HER2 Targeted Therapy.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Assessment of Ovarian Function in Phase III (Neo)Adjuvant Breast Cancer Clinical Trials: A Systematic Evaluation.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Circulating Tumor DNA Markers for Early Progression on Fulvestrant With or Without Palbociclib in ER+ Advanced Breast Cancer.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Baseline CD4<sup>+</sup> and expansion of γδ T cells correlate with response to durvalumab in triple‐negative breast cancer patients.
- Published in:
- Clinical & Translational Medicine, 2024, v. 14, n. 4, p. 1, doi. 10.1002/ctm2.1617
- By:
- Publication type:
- Article
Human leucocyte antigen class I in hormone receptor-positive, HER2-negative breast cancer: association with response and survival after neoadjuvant chemotherapy.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Fatal events during clinical trials: an evaluation of deaths during breast cancer studies.
- Published in:
- Breast Cancer (13406868), 2019, v. 26, n. 6, p. 826, doi. 10.1007/s12282-019-00990-3
- By:
- Publication type:
- Article
Neoadjuvant Clinical Trials for the Treatment of Primary Breast Cancer: The Experience of the German Study Groups.
- Published in:
- Current Oncology Reports, 2012, v. 14, n. 1, p. 27, doi. 10.1007/s11912-011-0212-x
- By:
- Publication type:
- Article
Radiotherapy statements of the 18th St. Gallen International Breast Cancer Consensus Conference—a German expert perspective.
- Published in:
- Strahlentherapie und Onkologie, 2024, v. 200, n. 6, p. 461, doi. 10.1007/s00066-024-02209-7
- By:
- Publication type:
- Article
Model-based optimization of G-CSF treatment during cytotoxic chemotherapy.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2018, v. 144, n. 2, p. 343, doi. 10.1007/s00432-017-2540-1
- By:
- Publication type:
- Article
Endocrine Therapy in Premenopausal Hormone Receptor Positive/Human Epidermal Growth Receptor 2 Negative Metastatic Breast Cancer: Between Guidelines and Literature.
- Published in:
- Oncologist, 2018, v. 23, n. 8, p. 974, doi. 10.1634/theoncologist.2018-0077
- By:
- Publication type:
- Article
Palbociclib Combined with Fulvestrant in Premenopausal Women with Advanced Breast Cancer and Prior Progression on Endocrine Therapy: PALOMA-3 Results.
- Published in:
- Oncologist, 2017, v. 22, n. 9, p. 1028, doi. 10.1634/theoncologist.2017-0072
- By:
- Publication type:
- Article
Bevacizumab Treatment for Advanced Breast Cancer.
- Published in:
- Oncologist, 2011, v. 16, n. 12, p. 1684, doi. 10.1634/theoncologist.2011-0113
- By:
- Publication type:
- Article
Classical pathology and mutational load of breast cancer – integration of two worlds.
- Published in:
- Journal of Pathology: Clinical Research, 2015, v. 1, n. 4, p. 225, doi. 10.1002/cjp2.25
- By:
- Publication type:
- Article
Neutropenic complications in the PANTHER phase III study of adjuvant tailored dose-dense chemotherapy in early breast cancer.
- Published in:
- Acta Oncologica, 2020, v. 59, n. 1, p. 75, doi. 10.1080/0284186X.2019.1670353
- By:
- Publication type:
- Article
The effect of denosumab on disseminated tumor cells (DTCs) of breast cancer patients with neoadjuvant treatment: a GeparX translational substudy.
- Published in:
- Breast Cancer Research, 2023, v. 25, n. 1, p. 1, doi. 10.1186/s13058-023-01619-2
- By:
- Publication type:
- Article
Prospective Validation of Immunological Infiltrate for Prediction of Response to Neoadjuvant Chemotherapy in HER2-Negative Breast Cancer – A Substudy of the Neoadjuvant GeparQuinto Trial.
- Published in:
- PLoS ONE, 2013, v. 8, n. 12, p. 1, doi. 10.1371/journal.pone.0079775
- By:
- Publication type:
- Article
Neutrophil Gelatinase-Associated Lipocalin (NGAL) Predicts Response to Neoadjuvant Chemotherapy and Clinical Outcome in Primary Human Breast Cancer.
- Published in:
- PLoS ONE, 2012, v. 7, n. 10, p. 1, doi. 10.1371/journal.pone.0045826
- By:
- Publication type:
- Article
Patient‐reported outcomes from KATHERINE: A phase 3 study of adjuvant trastuzumab emtansine versus trastuzumab in patients with residual invasive disease after neoadjuvant therapy for human epidermal growth factor receptor 2–positive breast cancer
- Published in:
- 2020
- By:
- Publication type:
- journal article
Efficacy and safety of tailored and dose-dense adjuvant chemotherapy and trastuzumab for resected HER2-positive breast cancer: Results from the phase 3 PANTHER trial.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Anti-cancer immune response mechanisms in neoadjuvant and targeted therapy.
- Published in:
- Seminars in Immunopathology, 2011, v. 33, n. 4, p. 341, doi. 10.1007/s00281-011-0261-0
- By:
- Publication type:
- Article
A randomized phase 2 study comparing EC or CMF versus nab-paclitaxel plus capecitabine as adjuvant chemotherapy for nonfrail elderly patients with moderate to high-risk early breast cancer (ICE II-GBG 52).
- Published in:
- 2015
- By:
- Publication type:
- journal article
Constitutive phosphorylated STAT3-associated gene signature is predictive for trastuzumab resistance in primary HER2-positive breast cancer.
- Published in:
- BMC Medicine, 2015, v. 13, n. 1, p. 177, doi. 10.1186/s12916-015-0416-2
- By:
- Publication type:
- Article
Correction to: TGFB-induced factor homeobox 1 (TGIF) expression in breast cancer.
- Published in:
- 2021
- By:
- Publication type:
- corrected article
TGFB-induced factor homeobox 1 (TGIF) expression in breast cancer.
- Published in:
- BMC Cancer, 2021, v. 21, n. 1, p. 1, doi. 10.1186/s12885-021-08656-0
- By:
- Publication type:
- Article